Darzalex Faspro
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
57894-503 -
Package NDC
57894-503-01 -
Application number
BLA761145 -
SPL ID
7f8d76d6-da40-408e-8dcc-e16df836db77 -
SPL set ID
4bb241af-4299-4373-8762-2d6709515db0 -
UNII
4Z63YK6E0E -
UNII
743QUY4VD8 -
RxCUI
2375136 -
RxCUI
2375141
What the source publishes
- Labeler
- Janssen Biotech, Inc.
- Active ingredients
- daratumumab and hyaluronidase-fihj (human recombinant)
- Form
- INJECTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- Darzalex Faspro
- daratumumab and hyaluronidase-fihj (human recombinant)
- DARATUMUMAB
- HYALURONIDASE (HUMAN RECOMBINANT)
Complete source data
{
"name": "Darzalex Faspro",
"splId": "7f8d76d6-da40-408e-8dcc-e16df836db77",
"labels": [
{
"setId": "4bb241af-4299-4373-8762-2d6709515db0",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4bb241af-4299-4373-8762-2d6709515db0",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4bb241af-4299-4373-8762-2d6709515db0"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Janssen Biotech, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) / 15 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "57894-503-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20200501"
}
],
"productId": "57894-503_7f8d76d6-da40-408e-8dcc-e16df836db77",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "57894-503",
"deaSchedule": null,
"genericName": "daratumumab and hyaluronidase-fihj (human recombinant)",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DARATUMUMAB",
"strength": "1800 mg/15mL"
},
{
"name": "HYALURONIDASE (HUMAN RECOMBINANT)",
"strength": "30000 U/15mL"
}
],
"applicationNumber": "BLA761145",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200501",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000192336",
"N0000192335",
"M0001357",
"N0000175531",
"M0009499"
],
"unii": [
"4Z63YK6E0E",
"743QUY4VD8"
],
"rxcui": [
"2375136",
"2375141"
],
"spl_set_id": [
"4bb241af-4299-4373-8762-2d6709515db0"
],
"pharm_class_cs": [
"Antibodies, Monoclonal [CS]",
"Glycoside Hydrolases [CS]"
],
"pharm_class_epc": [
"CD38-directed Cytolytic Antibody [EPC]",
"Endoglycosidase [EPC]"
],
"pharm_class_moa": [
"CD38-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"Janssen Biotech, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:57894-503_7f8d76d6-da40-408e-8dcc-e16df836db77"